Asking people touched by neurodegenerative diseases including Alzheimer’s disease or other forms of dementia and parkinsonian syndromes to share their stories and inform the campaign from the grassroots.
Launched today, www.mindonlinecampaign.com is asking people touched by neurodegenerative diseases including Alzheimer’s disease or other forms of dementia and parkinsonian syndromes to share their stories and inform the campaign from the grassroots.
“People who are touched by these diseases are at the core of the MIND campaign and we want to hear from them about how these diseases have affected their lives,” said Pascale Witz, President and CEO, GE Healthcare, Medical Diagnostics. “We are committed to improving things for patients and for caregivers, and will use our expertise and our voice to call on policymakers to act to alleviate the suffering caused by neurodegenerative disease.”
MIND Online is a component of the MIND – Making An Impact on Neurodegenerative Diseases – global campaign initiated by GE Healthcare to identify gaps in current frameworks for the detection, diagnosis, and care of neurodegenerative disease, and to propose viable solutions. GE Healthcare is partnering with expert organizations and individuals around the world, initially focusing on France, Germany, Japan, South Korea, the United Kingdom and the United States, to drive policy to support patients, families, and caregivers affected by neurodegenerative disease, and to examine ways to reduce the cost of disease management.
The campaign was launched in recognition of the serious impact of neurodegenerative diseases around the world. According to Alzheimer’s Disease International, approximately 36 million people are living with dementia, (including Alzheimer’s) and by 2050 the number of cases will more than triple. Additionally, according to the Parkinson’s Disease Foundation, 7-10 million are living with Parkinson’s worldwide.
“We are looking forward to working with GE Healthcare on the MIND campaign,” said Marc Wortmann, Executive Director of Alzheimer’s Disease International. “Together, we will find solutions that will positively impact the lives of millions of people living with the most prevalent forms of neurodegenerative disease.”